Rafael Torres
Family Medicine · Wilson, NCNPI 1285696716
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.8% of the total across 140 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 26 manufacturers, the largest accounting for just 17.6% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,477 and has fallen 81.1% since, to $279 in 2025.
Across 140 payments — averaging $23.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Redhill Biopharma Inc.$585
- Lilly USA, LLC$523
- Amgen$340
- Merck$310
- Johnson & Johnson$301
- Viiv Healthcare Company$290
- plus $972 from 20 others
What the payments were for
- Food & beverage$3,316100%
- Education$60%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Redhill Biopharma Inc. | 26 | $585 |
| Lilly USA, LLC | 14 | $523 |
| Amgen | 11 | $340 |
| Merck | 19 | $310 |
| Johnson & Johnson | 15 | $301 |
| Viiv Healthcare Company | 23 | $290 |
| Cequr Corporation | 1 | $136 |
| Novartis | 1 | $122 |
| Napo Pharmaceuticals Inc | 6 | $120 |
| Gilead | 2 | $111 |
| Theratechnologies Inc. | 5 | $96 |
| Janssen Products, LP | 1 | $81 |
| Rigel Pharmaceuticals, Inc. | 2 | $46 |
| Corcept Therapeutics | 1 | $34 |
| Sanofi-aventis U.S. LLC | 2 | $32 |
| Atricure, Inc. | 1 | $29 |
| Mylan Pharmaceuticals Inc. | 1 | $23 |
| GSK | 1 | $23 |
| Optos, Inc. | 1 | $20 |
| Radius Health, Inc. | 1 | $17 |
| Hikma Pharmaceuticals USA | 1 | $15 |
| Eyevance Pharmaceuticals LLC | 1 | $15 |
| Abbott | 1 | $14 |
| Zyla Life Sciences, Inc. | 1 | $13 |
| AbbVie | 1 | $13 |
| Mission Pharmacal Company | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,322 in reported general payments places this provider in the 85th percentile of 3,444 family medicine providers in North Carolina.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 12 | $1,161 |
| Valsartan | 18 | $492 |
| Metformin Hcl | 15 | $71 |
| Carvedilol | 17 | $71 |
| Hydralazine Hcl | 18 | $70 |
| Atorvastatin Calcium | 25 | $59 |
| Amlodipine Besylate | 14 | $28 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Wilson
- Wiley CockrellWilson$21K
- James SigmonWilson$16K
- William CromwellRaleigh$879K
- Steve VacalisGastonia$693K
- David DundeeWinston Salem$633K
- Kevin SodenCharlotte$558K
- Brian ForrestApex$398K
- Joseph KonenCharlotte$322K
- Richard RachimaCharlotte$294K
- Dimitrios HondrosCharlotte$275K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.